FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061670 [Registered on: 19/01/2024] Trial Registered Prospectively
Last Modified On: 13/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Reduction of pain on propofol injection after 6% Hydroxyethyl starch  
Scientific Title of Study   Pre-Administration of 6% Hydroxyethyl Starch For Reduction of Pain on Propofol Injection: A Placebo Controlled Randomised Study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr VEENA MATHUR 
Designation  HOD Department of anesthesiology JLN medical College and hospital 
Affiliation  JLN medical College and hospital 
Address  Department of Anesthesiology, New OT, first floor Jawahar Lal Nehru Medical College Kalabhag Ajmer Rajasthan

Ajmer
RAJASTHAN
305001
India 
Phone  9460517947  
Fax    
Email  veenamathur41@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr VEENA MATHUR 
Designation  HOD Department of Anesthesiology JLN medical College and hospital 
Affiliation  JLN medical College and hospital 
Address  Department of Anesthesiology, New OT, first floor Jawahar Lal Nehru Medical College and Hospital Kalabhag Ajmer Rajasthan

Ajmer
RAJASTHAN
305001
India 
Phone  9460517947  
Fax    
Email  veenamathur41@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr VEENA MATHUR 
Designation  HOD Department of Anesthesiology JLN medical College and hospital 
Affiliation  JLN Medical College and Hospital 
Address  Department of Anesthesiology, New OT, First floor , Jawahar Lal Nehru Medical College and Hospital Kalabhag Ajmer Rajasthan

Ajmer
RAJASTHAN
305001
India 
Phone  9460517947  
Fax    
Email  veenamathur41@gmail.com  
 
Source of Monetary or Material Support  
Department of anesthesiology JLN medical College and hospital, Kalabhag road Ajmer Rajasthan 305001 
 
Primary Sponsor  
Name  JLN medical College 
Address  Kalabhag Ajmer Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr VirukshaA  Jawahar Lal Nehru Medical College and Hospital  Department of Anesthesiology New OT , First floor, JLN Medical College and Hospital
Ajmer
RAJASTHAN 
9003473972

virukshaarun@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Jawahar Lal Nehru Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  0.9% Normal saline  With due approval from institutional ethical committee, placebo randomised study has been planned on 100 adult patients who will be undergoing General Anaesthesia, participants will be receiving 100 ml bolus over 3 to 5 minutes and then will be assessed for pain during propofol injection 
Intervention  6% hydroxyethyl starch  with due approval from institutional ethical committee, placebo randomised study has been planned on 100 adult patients who will be undergoing General Anaesthesia, participants will be alloted into Group 6%HES receiving HES and group 0.9%NS receiving normal saline in 100 ml bolus over 3 to 5 minutes and then will be assessed for pain during propofol injection, pain recall post operatively, a written informed consent will be taken from participants prior to procedure 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients undergoing elective surgery under general anaesthesia
ASA class 1 and 2 
 
ExclusionCriteria 
Details  Patients undergoing emergency surgery
Patients in whom hand or forearm veins are not accessible
Patients with comorbidites
Patient refusal 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Pain during propofol injection
Post operative pain recall 
Assessment of pain during propofol injection by Mc Crimick and hunter scale degree of pain during 2,5,10,20 seconds 
 
Secondary Outcome  
Outcome  TimePoints 
Haemodynamic changes
To compare the severity of propofol injection pain 
Baseline, 5minutes, 10 minutes, 20 minutes 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   24/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After thorough preoperative assessment of each patient, written informed consent will be taken. on arrival in the operating room, an 18 G cannula is inserted. No analgesic premedication will be given. The study drug HES/ NS will be drawn up in two 50 ml syrings and administer it over three to 5 minutes.once the 100 ml bolus is over, all patients will be premedicated with inj.glycopyrolate 0.004mg/ kg if and inj. Tramadol 2 mg/ kg if.Preoxygenation will be done with 100% O2 for 3 minutes. Induction will be done using inj. Propofol 1.2 to 2.5 mg/kg if administered till loss of verbal contact. During propofol injection pain will be assessed Evert 5 to 10 seconds before the loss of verbal contact as 0- no pain, 1-mild pain,2- moderate and 3 - severe using Mc Crimick and hunter scale, tracheal intubation will be facilitated with inj.succinylscholine 2mg/ kg.Trachea will be intubated. General anaesthesia will be maintained with oxygen , inj atracurium and supplemented with inhalational sevoflurane.Routine ASA monitoring will be established. The vital parameters will be recorded. All patients will be asked to recall if there was pain during injection of propofol in the recovery room and incidence of pain was graded as no recall of pain present. 
Close